Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes

被引:39
作者
McCoull, William [1 ]
Addie, Matthew S. [1 ]
Birch, Alan M. [1 ]
Birtles, Susan [1 ]
Buckett, Linda K. [1 ]
Butlin, Roger J. [1 ]
Bowker, Suzanne S. [1 ]
Boyd, Scott [1 ]
Chapman, Stephen [1 ]
Davies, Robert D. M. [1 ]
Donald, Craig S. [1 ]
Green, Clive P. [1 ]
Jenner, Chloe [1 ]
Kemmitt, Paul D. [1 ]
Leach, Andrew G. [1 ]
Moody, Graeme C. [1 ]
Gutierrez, Pablo Morentin [1 ]
Newcombe, Nicholas J. [1 ]
Nowak, Thorsten [1 ]
Packer, Martin J. [1 ]
Plowright, Alleyn T. [1 ]
Revill, John [1 ]
Schofield, Paul [1 ]
Sheldon, Chris [1 ]
Stokes, Steve [1 ]
Turnbull, Andrew V. [1 ]
Wang, Steven J. Y. [1 ]
Whalley, David P. [1 ]
Wood, J. Matthew [1 ]
机构
[1] AstraZeneca, Cardiovasc & Gastrointestinal Innovat Med Unit, Macclesfield SK10 4TG, Cheshire, England
关键词
DGAT; Oxadiazole; LLE; Obesity; PK/PD; DIACYLGLYCEROL ACYLTRANSFERASE-1 INHIBITORS; POTENT; DISCOVERY; DERIVATIVES; DESIGN;
D O I
10.1016/j.bmcl.2012.04.117
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of DGAT-1 inhibitors was discovered from an oxadiazole amide high throughput screening (HTS) hit. Optimisation of potency and ligand lipophilicity efficiency (LLE) resulted in a carboxylic acid containing clinical candidate 53 (AZD3988), which demonstrated excellent DGAT-1 potency (0.6 nM), good pharmacokinetics and pre-clinical in vivo efficacy that could be rationalised through a PK/PD relationship. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3873 / 3878
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 1987, J. Chemometrics, DOI DOI 10.1002/CEM.1180010107
[2]   Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability [J].
Bali, Ustav ;
Barba, Oscar ;
Dawson, Graham ;
Gattrell, William T. ;
Horswill, James G. ;
Pan, David A. ;
Procter, Martin J. ;
Rasamison, Chrystelle M. ;
Smith, Colin P. Sambrook ;
Taylor-Warne, Amanda ;
Wong-Kai-In, Philippe .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) :824-828
[3]  
Birch A.M., 2006, PCT Int. Appl., P418, Patent No. 2006418
[4]  
Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489
[5]   Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor [J].
Birch, Alan M. ;
Birtles, Susan ;
Buckett, Linda K. ;
Kemmitt, Paul D. ;
Smith, Graham J. ;
Smith, Tim J. D. ;
Turnbull, Andrew V. ;
Wang, Steven J. Y. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1558-1568
[6]  
Butlin R.J., 2006, PCT Int. Appl., P74, Patent No. 200674
[7]   A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions [J].
Buttar, David ;
Colclough, Nicola ;
Gerhardt, Stefan ;
MacFaul, Philip A. ;
Phillips, Scott D. ;
Plowright, Alleyn ;
Whittamore, Paul ;
Tam, Kin ;
Maskos, Klaus ;
Steinbacher, Stefan ;
Steuber, Holger .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (21) :7486-7496
[8]   Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases [J].
Cao, Jingsong ;
Zhou, Yingjiang ;
Peng, Haibing ;
Huang, Xinyi ;
Stahler, Shannon ;
Suri, Vipin ;
Qadri, Ariful ;
Gareski, Tiffany ;
Jones, Juli ;
Hahm, Seung ;
Perreault, Mylene ;
McKew, John ;
Shi, Mengxiao ;
Xu, Xin ;
Tobin, James F. ;
Gimeno, Ruth E. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) :41838-41851
[9]   Inhibition of triglyceride synthesis as a treatment strategy for obesity - Lessons from DGAT1-deficient mice [J].
Chen, HC ;
Farese, RV .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) :482-486
[10]   Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core [J].
Dow, Robert L. ;
Andrews, Melissa ;
Aspnes, Gary E. ;
Balan, Gayatri ;
Gibbs, E. Michael ;
Guzman-Perez, Angel ;
Karki, Kapil ;
LaPerle, Jennifer L. ;
Li, Jian-Cheng ;
Litchfield, John ;
Munchhof, Michael J. ;
Perreault, Christian ;
Patel, Leena .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) :6122-6125